Intuitive Surgical, Inc. has recently been in the spotlight for investors. The company, famous for its
$1 million surgical robots, has demonstrated promising financial growth with its Q4 revenues soaring 25% to $2.41 billion, surpassing street estimates. Despite sold shares by entities like Waycross Partners LLC, Global Retirement Partners, and others, new stakes have been acquired by the likes of Sovran Advisors LLC and WD Rutherford LLC. However, speculation looms as to whether the stock could face difficulties this year. Stock experts and advisors have posited differing views on whether to buy, sell, or hold post Q4 earnings. Amid these discussions, ISRG's consistently high performance and innovation in robotic surgery and AI-driven Da Vinci systems have been highlighted. However, questions remain about the stock's valuation, especially after nearly a 60% surge. Despite this, numerous investors remain confident in its potential, indicating the possibility of the stock reaching $5,000 or even hitting a trillion-dollar market cap by 2040.
Intuitive Surgical ISRG News Analytics from Wed, 04 Sep 2024 07:00:00 GMT to Fri, 21 Feb 2025 11:58:48 GMT -
Rating 7
- Innovation 6
- Rumor -4
